Entries by

BIO-Europe Spring® Conference in Turin, March 10-12, 2014

BIO-Europe Spring® Conference in Turin/Italy 2014, March 10-12. For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on living cells please send a meeting invitation via the conference partnering system to Dr. Paul Helbling. Alternatively, you can reach Dr. Paul Helbling via email…

Dualsystems Biotech partners with IBR Inc. to validate the workflow of the CaptiRec Technology

Dualsystems Biotech AG Press Release Dualsystems Biotech partners with IBR Inc. to validate the workflow of the CaptiRec Technology Schlieren, Switzerland, January 2014: – Dualsystems Biotech AG has announced it will collaborate with another Swiss laboratory, Institute for Biopharmaceutical Research (IBR Inc.) to validate the CaptiRec Triceps/Ligand Receptor Capture Technology. This technology is used to…

Swiss Biotech Day 2014, 8. April

The Swiss Biotech Day on 8 April 2014 is the leading biotechnology conference in Switzerland. Every year, this event brings together more than 200 senior executives from the life science industry across Europe. For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on…

Dualsystems closes Series C Financing Round

Dualsystems Biotech  has closed a Series C financing round with support from existing and new investors to implement and drive forward its new business strategy in mass spectrometry based protein interaction discovery.

Licensing Agreement with ETH Zurich on LRC technoloy

Dualsystems Biotech closes Licensing Agreement with ETH Zurich on Ligand Receptor Capture (LRC) technology Dualsystems Biotech has licensed an innovative technology to discover cell-surface receptors for a vast range of ligands of interest. LRC is centered around an innovative trifunctional chemoproteomic reagent named TriCEPS™, which enables the unbiased identification of cell surface receptors for many…